RIO DE JANEIRO, BRAZIL - Brazil made a diplomatic push on Monday, January 4th, to guarantee shipment of an Indian-made Covid-19 vaccine of British drugmaker AstraZeneca, hoping to avoid export restrictions that could delay immunizations in the country with the world's second-deadliest outbreak.
In parallel, Brazil's private clinics struck a preliminary deal for an alternative injection made by India's Bharat Biotech, despite a lack of published results from late-stage trials.
The scramble by Brazil's government and private sector underscored how Latin America's largest nation, once an example of mass immunization success in . . .